Skip to main content

Table 3 Average costs of genital herpes per patient in first and recurrent episodes

From: The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

  First episode % % of total Recurrent episode % % of total
Medical costs       
Consultations 62.6 35.8%   59.6 47.3%  
Clinical examination 39.8 22.7%   36.2 28.7%  
Microbiologic tests 17.6 10.1%   6.7 5.3%  
Antibody testing 12.8 7.3%   6.5 5.2%  
Complete blood count 4.6 2.6%   1.5 1.2%  
Urine analysis 4.6 2.6%   3.2 2.5%  
Others 33.0 18.9%   12.3 9.8%  
Total 175.0 100% 58.3% 126.0 100% 38.8%
Drug treatment       
Antiviral treatment 64.0 100%   131.0 100%  
Total 64.0 100% 21.3% 131.0 100% 40.3%
Hospital       
Hospitalization 1.0   0.4% 8.0   2.4%
Total direct costs 240.0   80.0% 265.0   81.5%
Indirect costs       
Production losses 60.0   20.0% 60.0   18.5%
Total costs per patient 300.0   100% 325.0   100%
  1. Note: Costs are expressed in 1996 US$.